Beware of thromboembolic risk in obese patients on direct oral anticoagulants (DOACs).

Editor – We read with interest the article by Burden et al on pulmonary embolism in a patient on rivaroxaban and concurrent carbamazepine.[1][1] While the authors highlight the interaction between rivaroxaban and carbamazepine, one should be mindful of other risk factors that might reduce the